-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse StuttgartEURSymbol R5X-
ACELRX PHARMACEUTICALS INCBörse Börse StuttgartEURSymbol R5X
-
ACELRX PHARMACEUTICALS INCBörse Gettex System der Börse MünchenEURSymbol R5X
-
ACELRX PHARMACEUTICALS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol R5X
-
AcelRx PharmaceuticalsBörse NasdaqISIN US00444T1007 WKN: A1H64BUSDSymbol ACRX
-
ISIN US00444T1007 WKN: A1H64BUSDSymbol ACRX
-
EURSymbol R5X
-
EURSymbol R5X
-
EURSymbol R5X
-
Symbol R5X
Währung
EUR
Börse
Börse Stuttgart Zeitzone: Europe/Berlin
Firmenname
AcelRx Pharmaceuticals, Inc
Marktkapitalisierung
213.161.472 (+- 40%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
299.322.944 oder 127.000.000
Mitarbeiter
71 (+- 39%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
99 oder 43 Mitarbeiter
EBITDA -44.968.000
Buchwert -0.233
Dir gefallen die Informationen zu AcelRx Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AcelRx Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu AcelRx Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu AcelRx Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
21 News & Informationen zur AcelRx Pharmaceuticals Aktie
AcelRx Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Investors with losses are encouraged to contact the firm before August 9, 2021; click here to submit trade information LOS ANGELES, July 30, 2021 …
AcelRx Pharmaceuticals : Changes in Registrant's Certifying Accountant (Form 8-K)
July 29, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-7561
Ladies and Gentlemen:
… | July 29, 2021
The Law Offices Of Frank R. Cruz Announces The Filing Of A Securities Class Action On Behalf Of AcelRx Pharmaceuticals, Inc. (ACRX) Investors
LOS ANGELES, July 21, 2021 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)
LOS ANGELES, July 20, 2021 — Glancy Prongay & Murray LLP reminds investors of the upcoming August 9, 2021 deadline to file a lead plaintiff motion in the class action filed…
DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 20, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
Public debt market steady in May-June
In 2021 Q2, there was a shift in individual investors' preferences towards Russian shares. Further details are available in the new issue of the Financial Market Risks Review. …
DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 08, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm
NEW YORK, July 07, 2021 — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of…
DEADLINE ALERT for FREQ, ACRX, RLX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
BENSALEM, Pa., July 06, 2021 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of…
AcelRx Pharmaceuticals : ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX
NEW YORK, July 4, 2021 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor… | July 4, 2021
SHAREHOLDER ALERT: Robbins LLP Reminds Investors That AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of all purchasers of AcelRx Therapeutics, Inc. securities between March 17, 2020 and February… | July 1, 2021
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)
BENSALEM, Pa., July 1, 2021 /PRNewswire/ — Law Offices of Howard G. Smith reminds investors of the upcoming August 9, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of… | July 1, 2021
DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 01, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
AcelRx Pharmaceuticals : The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors
LOS ANGELES, June 25, 2021 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise… | June 25, 2021
AcelRx Pharmaceuticals : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Cla
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. between March 17, 2020 and February 12, 2021, inclusive , of the… | June 23, 2021
Portnoy Law: Lawsuit Filed On Behalf of AcelRx Pharmaceuticals, Inc. Investors
Click here to join the case LOS ANGELES, June 22, 2021 — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of AcelRx Pharmaceuticals, Inc. …
Is IZEA Worldwide Inc. (IZEA) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on…
Are You Following Analysts On These Penny Stocks?
This year has gotten off to a strong start already. Many stocks, including penny stocks, are reaching new 52-week and all-time highs. Meanwhile, the broader …
Top Penny Stocks To Buy According To 4 Analysts & Targets Up To 265%
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
REDWOOD CITY, Calif., Jan. 14, 2021 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the …
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 12) …